NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -125.06% | 732.84% | 0.00% | 23.53% | 50.68% |
| Total Depreciation and Amortization | -30.91% | -42.11% | 0.00% | 5.56% | -6.25% |
| Total Amortization of Deferred Charges | -23.08% | 766.67% | -97.93% | -53.38% | -25.06% |
| Total Other Non-Cash Items | -99.39% | 858.62% | -495.45% | -96.46% | -64.03% |
| Change in Net Operating Assets | -181.63% | 482.53% | 120.61% | -6,072.22% | -106.77% |
| Cash from Operations | -130.26% | 1,102.57% | 52.84% | -255.34% | 18.08% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | 100.00% | -27.01% | -7.61% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | 1,173.89% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.41% | -- | -- | 100.00% | -405.26% |
| Cash from Financing | 89.81% | -441.60% | -76.07% | 524.59% | 17.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.86% | 2,422.83% | -1,430.77% | 102.43% | 17.98% |